Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Maturitas: Clinical Guide on Low-dose Vaginal Estrogens for Vaginal Atrophy | |
Elsevier announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas.
The society published a clinical guide on low-dose vaginal estrogens for postmenopausal vaginal atrophy also including a summary of recommendations.
Vaginal atrophy is common after menopause and adversely affects quality of life in one out of every two women. This guide provides the evidence for the clinical use of low-dose vaginal estrogens for this condition, focusing on publications since the 2006 Cochrane systematic review. The guide concludes that low-dose vaginal estrogens are effective and that there is no need for added progestogens for endometrial protection if topical estrogens are used in the recommended doses. With regard to duration of use, recommendations vary among patients, but vaginal atrophy is a chronic condition and will recur on cessation of treatment. Thus annual review would be prudent.
These and other recommendations presented in the EMAS clinical guide are published in the article: "EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy" by Margaret Rees, Faustino R. Pérez-López, Iuliana Ceasu, Herman Depepyre, Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Yvonne van der Schouw, and Florence Tremollieres The article appears in Maturitas Volume 73, Issue 2 (October 2012) published by Elsevier.
Source-Eurekalert
| |
|
|
More News on: Hormone Replacement Therapy, Uterine Cancer
 Comment & Contribute
|
Related Links
Dispel Myths About Vitiligo, Say Experts
A lot of social stigma is attached to vitiligo and adolescents who are afflicted often slip into depression, say doctors. The social stigma is ...
Viral Meningitis Causes Strange Behavior in a 36-year-old Woman
Thirty one year old Samantha Vaughan began to behave strangely after contracting viral meningitis. She seemed to take on multiple personalities ...
Scientists Reveal Origin of Human Hips
The evolution of weight-bearing hips of walking animals is much simpler process than thought, says research. Tetrapods, or ...
Research: PARP Inhibitor Shows Activity in Pancreatic, Prostate Cancers Among Patients Carrying BRCA Mutations
The oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers in the largest clinical trial to date to examine ...
Genome Sequencing may Shed Light on Parrots' Longevity and Intelligence: Researchers
The complete genome of a Scarlet macaw was successfully sequenced for the first time by researchers at Texas A and M University. This ...
Promising Treatment for Progeria on the Anvil
A new study has brought the possibility of a treatment for progeria closer to reality. "This study is a breakthrough for our research ...
- Health News Index
- News Quick Links
| News Categories: |
| » | EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk |
| » | Reduce Ambien's Dose to Avoid Drowsy Driving |
| » | Statins Cut Exercise Benefits |
| » | New Drug Enhances Radiation Treatment for Brain Cancer |
| » | Experts Issue Warning Against Online Sexual Enhancement Pills |
| More Drug News | |
|
Ask an Expert
